HEALTH NEWS
Study Title:
EPA/DHA Intake and Disease Biomarkers
Study Abstract
Background: Few studies have examined the associations of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) with biomarkers of chronic disease risk in populations with high intakes.
Objective: We examined the associations of red blood cell (RBC) EPA and DHA, as percentages of total fatty acids, with biomarkers of chronic disease risk across a wide range of EPA and DHA intakes.
Design: In a cross-sectional study of 357 Yup'ik Eskimos, generalized additive models were used to plot covariate-adjusted associations of EPA and DHA with chronic disease biomarkers. Linear regression models were used to test for the statistical significance of these associations.
Results: Means (5th–95th percentiles) for RBC EPA and DHA were 2.8% (0.5–5.9%) and 6.8% (3.3–9.0%), respectively. Associations of EPA and DHA were inverse and linear for triglycerides (β ± SE = –0.10 ± 0.01 and –0.05 ± 0.01, respectively) and positive and linear for HDL cholesterol (β ± SE = 2.0 ± 0.5 and 0.9 ± 0.6, respectively) and apolipoprotein A-I (β ± SE = 2.6 ± 0.8 and 1.7 ± 0.8, respectively). Positive linear associations of DHA with LDL and total cholesterol (β ± SE = 7.5 ± 1.4 and 6.80 ± 1.57, respectively) were observed; for EPA, these associations were nonlinear and restricted to concentrations <5% of total fatty acids. Associations of EPA and DHA with C-reactive protein were inverse and nonlinear: for EPA, the association appeared stronger at concentrations >3% of total fatty acids; for DHA, it was observed only at concentrations >7% of total fatty acids.
Conclusion: Increasing EPA and DHA intakes to amounts well above those consumed by the general US population may have strong beneficial effects on chronic disease risk.
Study Information
Zeina Makhoul, Alan R Kristal, Roman Gulati, Bret Luick, Andrea Bersamin, Bert Boyer and Gerald V MohattAssociations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos.
Am J Clin Nutr
2010 March
Division of Public Health Sciences Fred Hutchinson Cancer Research Center Seattle WA.
Recent News
Arabinogalactan Boosts Lymph Flow and Immunity
Protect Your Gut Mucosal Barrier for Immune Health and Vitality
The Truth About Sugar Substitutes: Are Stevia, Sucralose, and Saccharin Safe?
Boost Your Digestive Power for Better Nutrient Absorption and Gut Health
MTHFR Gene and The Importance of Methyl B12 and Methyl Folate